PureTech Health (PRTC) Competitors

PureTech Health (NASDAQ:PRTC) and Edgewise Therapeutics (NASDAQ:EWTX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Is PRTC or EWTX more profitable?

PureTech Health's return on equity of 0.00% beat Edgewise Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PureTech Health	N/A	N/A	N/A
Edgewise Therapeutics	N/A	-26.83%	-25.67%

Do insiders & institutionals have more ownership in PRTC or EWTX?

0.0% of PureTech Health shares are held by institutional investors. 5.3% of PureTech Health shares are held by insiders. Comparatively, 24.1% of Edgewise Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community believe in PRTC or EWTX?

Edgewise Therapeutics received 31 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 72.73% of users gave Edgewise Therapeutics an outperform vote while only 45.00% of users gave PureTech Health an outperform vote.

Company	Underperform	Outperform
PureTech Health	Outperform Votes 9 45.00%	Underperform Votes 11 55.00%
Edgewise Therapeutics	Outperform Votes 40 72.73%	Underperform Votes 15 27.27%

Which has higher earnings & valuation, PRTC or EWTX?

PureTech Health has higher revenue and earnings than Edgewise Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PureTech Health	$3.33M	124.49	-$65.70M	N/A	N/A
Edgewise Therapeutics	N/A	N/A	-$100.16M	-$1.45	-11.31

Which has more volatility & risk, PRTC or EWTX?

PureTech Health has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Edgewise Therapeutics has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500.

Does the media favor PRTC or EWTX?

In the previous week, Edgewise Therapeutics had 5 more articles in the media than PureTech Health. MarketBeat recorded 7 mentions for Edgewise Therapeutics and 2 mentions for PureTech Health. Edgewise Therapeutics' average media sentiment score of 1.31 beat PureTech Health's score of 0.94 indicating that Edgewise Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PureTech Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edgewise Therapeutics	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend PRTC or EWTX?

PureTech Health presently has a consensus price target of $45.00, indicating a potential upside of 160.72%. Edgewise Therapeutics has a consensus price target of $40.22, indicating a potential upside of 145.26%. Given PureTech Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe PureTech Health is more favorable than Edgewise Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PureTech Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Edgewise Therapeutics	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

PureTech Health beats Edgewise Therapeutics on 9 of the 15 factors compared between the two stocks.